Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Alpdogan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cytotherapy|July 26, 2005
IL-15: targeting CD8+ T cells for immunotherapyA Diab, A D Cohen, O Alpdogan, et al.
Internal Medicine (Tokyo, Japan)|April 1, 1995
The effect of 1,25 dihydroxyvitamin D3 on lymphocyte transformation in patients with chronic renal failureO Alpdogan, S Ozgun, R Lawrence, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 13, 2014
Coexistence of gallbladder agenesis and cholangiocarcinoma: report of a caseO Yoldas, P Yazıcı, I Ozsan, et al.
British Journal of Haematology|January 14, 1999
Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with idiopathic thrombocytopenic purpuraO Alpdogan, T Budak-Alpdogan, S Ratip, et al.
British Journal of Rheumatology|December 16, 1998
Skin hyperreactivity of Behçet's patients (pathergy reaction) is also positive in interferon alpha-treated chronic myeloid leukaemia patients, indicating similarly altered neutrophil functions in both disordersT Budak-Alpdogan, Demirçay, O Alpdogan, et al.
Bone Marrow Transplantation|April 30, 2013
Interleukin-15 administration increases graft-versus-tumor activity in recipients of haploidentical hematopoietic SCTC T Sauter, C P Bailey, M M Panis, et al.
Bone Marrow Transplantation|February 26, 2013
Haploidentical hematopoietic SCT increases graft-versus-tumor effect against renal cell carcinomaT Budak-Alpdogan, C T Sauter, C P Bailey, et al.
Blood|April 21, 2001
Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effectC Schmaltz, O Alpdogan, K J Horndasch, et al.
Blood|September 25, 2001
Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host diseaseO Alpdogan, C Schmaltz, S J Muriglan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cytotherapy|July 26, 2005
IL-15: targeting CD8+ T cells for immunotherapyA Diab, A D Cohen, O Alpdogan, et al.
Internal Medicine (Tokyo, Japan)|April 1, 1995
The effect of 1,25 dihydroxyvitamin D3 on lymphocyte transformation in patients with chronic renal failureO Alpdogan, S Ozgun, R Lawrence, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 13, 2014
Coexistence of gallbladder agenesis and cholangiocarcinoma: report of a caseO Yoldas, P Yazıcı, I Ozsan, et al.
British Journal of Haematology|January 14, 1999
Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with idiopathic thrombocytopenic purpuraO Alpdogan, T Budak-Alpdogan, S Ratip, et al.
British Journal of Rheumatology|December 16, 1998
Skin hyperreactivity of Behçet's patients (pathergy reaction) is also positive in interferon alpha-treated chronic myeloid leukaemia patients, indicating similarly altered neutrophil functions in both disordersT Budak-Alpdogan, Demirçay, O Alpdogan, et al.
Bone Marrow Transplantation|April 30, 2013
Interleukin-15 administration increases graft-versus-tumor activity in recipients of haploidentical hematopoietic SCTC T Sauter, C P Bailey, M M Panis, et al.
Bone Marrow Transplantation|February 26, 2013
Haploidentical hematopoietic SCT increases graft-versus-tumor effect against renal cell carcinomaT Budak-Alpdogan, C T Sauter, C P Bailey, et al.
Blood|April 21, 2001
Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effectC Schmaltz, O Alpdogan, K J Horndasch, et al.
Blood|September 25, 2001
Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host diseaseO Alpdogan, C Schmaltz, S J Muriglan, et al.
Pageof 1